0%

Shocking Side Effects of Ashwagandha — What 85% of Users Overlook in 2026

What we know about ashwagandha's side effects, clinical evidence, and safety considerations for informed use in 2026.

Dr. Alistair Sterling, MD
Dr. Alistair Sterling, MD
Chief Medical Officer • Medical Review Board
EVIDENCE-BASED & CLINICALLY VERIFIED • 2026/2/26
This article is for general health education only and is not a substitute for professional medical care. Anyone with chronic illness, complex medication regimens, pregnancy or breastfeeding, or recent significant symptoms should discuss changes in diet, supplements, or exercise plans with a qualified clinician.

1. Introduction to Ashwagandha: Clinical Context and Prevalence of Use

Introduction to Ashwagandha: Clinical Context and Prevalence of Use

Ashwagandha (Withania somnifera) is a prominent botanical in the traditional Ayurvedic system of medicine, where it has been used for centuries as a Rasayana, or rejuvenating tonic. In contemporary clinical and consumer contexts, it is primarily classified as an adaptogen—a substance theorized to help the body resist stressors and restore physiological homeostasis. Its rise to global prominence reflects a broader trend toward integrative and complementary health approaches.

Current prevalence of use is significant and continues to grow. Market analyses and health surveys indicate ashwagandha is among the most widely consumed herbal supplements in North America, Europe, and other regions. This widespread adoption is driven by several factors:

  • Perceived Benefits for Stress and Sleep: A body of clinical research, including randomized controlled trials (RCTs), suggests potential benefits for reducing perceived stress and improving sleep quality in certain populations.
  • Accessibility: It is readily available over-the-counter in various forms (capsules, powders, tinctures) without a prescription.
  • Cultural Integration: Its long history in Ayurveda lends an aura of traditional wisdom and natural safety, which strongly influences consumer choice.

However, the clinical evidence base requires careful navigation. While some RCTs show positive effects for stress, anxiety, and sleep parameters, the overall quality of evidence is mixed. Key limitations often include:

  • Small sample sizes and short study durations.
  • Variability in extract types, standardization (e.g., to withanolide content), and dosages.
  • A relative lack of long-term safety and efficacy data compared to conventional pharmaceuticals.

Clinical Perspective: From a medical standpoint, ashwagandha is not a first-line treatment for any diagnosed medical condition. Its role is generally considered within a supportive or complementary framework. Clinicians emphasize that "natural" does not equate to "risk-free," and its pharmacological activity necessitates the same caution as any other bioactive compound.

Certain individuals should exercise particular caution and consult a healthcare provider before use. This includes pregnant or breastfeeding women, individuals with autoimmune diseases, thyroid disorders, or those taking medications for diabetes, hypertension, anxiety, depression, or immunosuppression, due to potential interactions and physiological effects.

Understanding this clinical context and the nuances of the evidence is foundational for a responsible discussion of its side effect profile, which is often underappreciated amidst its popularity.

2. Evidence-Based Mechanisms and Pharmacological Profile

Evidence-Based Mechanisms and Pharmacological Profile

Ashwagandha (Withania somnifera) is classified as an adaptogen, a substance theorized to help the body resist physiological and psychological stress. Its pharmacological activity is attributed to a complex mixture of bioactive compounds, primarily withanolides (steroidal lactones like withaferin A and withanolide D), alkaloids, and sitoindosides. These constituents interact with multiple pathways in the central nervous, endocrine, and immune systems.

Primary Mechanisms of Action

The most well-substantiated mechanism involves modulation of the hypothalamic-pituitary-adrenal (HPA) axis. Clinical studies consistently show that standardized ashwagandha extract can significantly reduce serum cortisol levels, a key stress hormone. This effect is considered a cornerstone of its purported anti-stress and anxiolytic benefits.

Other evidence-supported mechanisms include:

  • GABAergic Activity: Ashwagandha may exert calming effects by modulating gamma-aminobutyric acid (GABA) receptors, similar to some anxiolytic medications, though this is primarily based on preclinical models.
  • Anti-inflammatory and Antioxidant Effects: Withanolides demonstrate potent anti-inflammatory and free-radical scavenging properties in laboratory studies, which may underlie observed benefits for markers of systemic inflammation.
  • Thyroid Hormone Modulation: Some clinical trials indicate it may increase serum levels of thyroxine (T4) in subclinical hypothyroid patients, suggesting a potential stimulatory effect on thyroid function.

Areas of Emerging or Mixed Evidence

While the cortisol-lowering effect is robust, evidence for other mechanisms in humans is more preliminary. Claims regarding direct neurogenesis, significant testosterone boosting in healthy individuals, or anti-cancer effects in humans are largely extrapolated from cell-culture or animal studies. Human data is often from small, short-duration trials, and results can be inconsistent.

Clinical Perspective: The multi-target pharmacology of ashwagandha explains both its potential benefits and its risk of side effects or drug interactions. Its influence on the HPA axis, thyroid, and GABA pathways means it is not a benign supplement for all. Effects can be dose-dependent and vary significantly based on the product's standardization and an individual's underlying physiology.

Who Should Exercise Caution: Individuals with thyroid disorders (especially hyperthyroidism or those on thyroid medication), autoimmune diseases, those taking sedatives, anti-hypertensives, or immunosuppressants, and pregnant or breastfeeding women should consult a physician before use. The pharmacological activity necessitates this precaution.

3. Potential Adverse Effects and Contraindicated Populations

Potential Adverse Effects and Contraindicated Populations

While ashwagandha is generally well-tolerated in the short term by many individuals, a comprehensive understanding of its potential adverse effects and contraindications is essential for safe use. The most commonly reported side effects are mild and gastrointestinal, such as nausea, diarrhea, or abdominal discomfort. These often subside with continued use or by taking the supplement with food.

More significant concerns, supported by clinical case reports and pharmacodynamic understanding, include:

  • Sedation and CNS Depression: Due to its anxiolytic properties, ashwagandha can cause drowsiness and potentiate the effects of other sedatives like benzodiazepines, barbiturates, or alcohol.
  • Thyroid Hormone Modulation: Evidence from human trials suggests it may increase serum T4 and, to a lesser extent, T3 levels. This is a critical consideration for individuals with thyroid disorders, particularly hyperthyroidism or those on thyroid hormone replacement therapy.
  • Hypoglycemic Effects: Animal and some human studies indicate it may lower blood glucose levels, necessitating caution for those with diabetes or hypoglycemia, especially when using glucose-lowering medications.
  • Immunostimulation: Its potential to stimulate immune function means it is contraindicated for individuals with autoimmune diseases (e.g., rheumatoid arthritis, lupus, multiple sclerosis) unless under strict specialist supervision.

The evidence for other effects, such as liver toxicity (hepatotoxicity), is more limited and primarily based on isolated case reports. However, it underscores the need for monitoring, particularly with long-term use or high doses.

Clinical Insight: From a pharmacological perspective, ashwagandha is not an inert herb. Its interactions are primarily theoretical but plausible based on its known physiological effects. The most significant clinical risk often involves polypharmacy—where a patient on multiple medications adds an herbal supplement without considering cumulative sedative, hypoglycemic, or hormonal effects. A thorough medication review is a prerequisite.

Contraindicated and High-Risk Populations

Certain populations should avoid ashwagandha or use it only under direct medical supervision:

  • Pregnant and Breastfeeding Individuals: It is traditionally considered abortifacient and emmenagogue (may stimulate menstrual flow). Due to a lack of safety data, its use is contraindicated.
  • Individuals Scheduled for Surgery: Due to potential sedative and hypoglycemic effects, it should be discontinued at least two weeks prior to any surgical procedure.
  • Those with Hormone-Sensitive Cancers: Given its potential influence on hormone pathways (e.g., thyroid, possibly sex hormones), individuals with cancers of the prostate, breast, or uterus should avoid it.
  • People with Peptic Ulcers: It may increase stomach acid secretion.

Anyone considering ashwagandha, especially those with pre-existing medical conditions or who are taking prescription medications, should consult a physician or a qualified healthcare provider for personalized advice. Self-supplementation without professional guidance can overlook these critical interactions and contraindications.

4. Practical Clinical Takeaways for Informed Use

Practical Clinical Takeaways for Informed Use

Informed use of ashwagandha requires a nuanced understanding of its evidence base and a personalized approach to risk assessment. The following clinical takeaways are designed to guide decision-making based on current scientific literature and standard safety protocols.

Evidence-Based Recommendations

The strongest evidence for ashwagandha root extract supports its use for reducing perceived stress and improving sleep quality in individuals with diagnosed stress-related conditions. This is typically based on standardized extracts (e.g., 300–600 mg daily of an extract standardized to 1.5% or 5% withanolides) used in trials lasting 8 to 12 weeks. Evidence for benefits on testosterone, muscle strength, or cognitive function is more preliminary, often derived from smaller studies or specific populations, and should not be considered conclusive.

  • Start Low, Go Slow: Initiate with the lowest studied dose (e.g., 300 mg daily) to assess individual tolerance before considering any increase.
  • Cycle Use: Given the lack of long-term safety data beyond 3-4 months, consider periodic breaks (e.g., 4-8 weeks on, 1-2 weeks off) rather than continuous, indefinite use.
  • Standardize Your Source: Select products from reputable manufacturers that provide a Certificate of Analysis (CoA) verifying withanolide content and the absence of heavy metals and microbial contaminants.

Essential Precautions and Contraindications

Certain individuals should exercise extreme caution or avoid ashwagandha entirely. A pre-use consultation with a physician is strongly advised for these groups:

  • Individuals with autoimmune diseases (e.g., rheumatoid arthritis, lupus, Hashimoto's thyroiditis), due to its potential immunostimulant effects.
  • Those taking medications for thyroid disorders, diabetes, hypertension, anxiety, or insomnia, as ashwagandha may potentiate drug effects, leading to hypoglycemia or hypotension.
  • Pregnant or breastfeeding women, due to a lack of safety data and theoretical abortifacient properties.
  • Individuals scheduled for surgery, as it may interact with anesthesia and affect blood pressure and glucose control.
  • Those with a history of hormone-sensitive cancers or prostate issues, given its uncertain effects on hormonal pathways.

Clinical Insight: From a pharmacovigilance perspective, the most commonly overlooked interactions are with sedative and anti-anxiety medications (e.g., benzodiazepines) and thyroid hormone replacement. Patients often do not disclose supplement use to their clinicians. A thorough medication reconciliation that includes all over-the-counter products is essential to prevent adverse synergistic effects.

Ultimately, ashwagandha is not a benign tonic. Its use should be a deliberate, evidence-informed choice, not a default wellness practice. Discontinue use and seek medical advice if you experience symptoms of liver injury (e.g., jaundice, dark urine, severe fatigue), significant sedation, or gastrointestinal distress.

5. Safety Protocols and Indications for Medical Consultation

Safety Protocols and Indications for Medical Consultation

While ashwagandha is generally well-tolerated in the short term by many individuals, a proactive safety protocol is essential to mitigate risks. This involves a systematic approach to initiation, monitoring, and knowing when to seek professional guidance.

Core Safety Protocols

Adhering to these foundational steps can significantly enhance safe use:

  • Start Low, Go Slow: Initiate with the lowest effective dose, typically 250–300 mg of a standardized root extract, and only increase gradually if needed after several weeks.
  • Cycle Usage: Consider a cycling protocol, such as taking ashwagandha for 8-12 weeks followed by a 2-4 week break, to assess ongoing need and reduce the risk of tolerance or subtle side effects.
  • Source Quality: Select products from reputable manufacturers that provide third-party verification for purity, standardized withanolide content, and absence of heavy metals.
  • Monitor for Reactions: Keep a simple log to note any changes in sleep, mood, digestion, energy levels, or heart rate, especially during the first few weeks.

Clinical Insight: The "start low, go slow" principle is particularly crucial with adaptogens. Their effects on the hypothalamic-pituitary-adrenal (HPA) axis are modulatory, not stimulatory. A gradual introduction allows the body's systems to adjust without provoking an excessive response, which can manifest as agitation, insomnia, or gastrointestinal upset in sensitive individuals.

Clear Indications for Medical Consultation

Certain situations, symptoms, or pre-existing conditions necessitate pausing use and consulting a healthcare provider. This is not a substitute for professional medical advice.

  • Pre-Existing Conditions: Individuals with autoimmune diseases (e.g., rheumatoid arthritis, lupus), thyroid disorders (especially hyperthyroidism), or hormone-sensitive cancers should avoid use unless explicitly approved by their specialist.
  • Concurrent Medication Use: Consultation is mandatory if taking sedatives, anti-anxiety drugs, thyroid hormone medication, immunosuppressants, or drugs for diabetes or hypertension, due to potential interactions.
  • Specific Populations: Pregnant or breastfeeding women, children, and individuals with scheduled surgery should avoid ashwagandha unless under direct medical supervision.
  • Emergent Symptoms: Discontinue use and seek prompt medical advice if experiencing signs of liver irritation (yellowing skin, dark urine, persistent nausea), significant sedation, palpitations, or symptoms suggestive of hyperthyroidism (unintended weight loss, rapid heartbeat, heat intolerance).

Ultimately, integrating ashwagandha into a health regimen should be an informed decision made in context with one's overall health profile. A brief discussion with a physician or a pharmacist can help assess individual risk factors, ensuring the approach is both evidence-informed and personally safe.

6. Questions & Expert Insights

Is Ashwagandha truly a "miracle herb" for stress and anxiety?

While some clinical studies show promise, labeling it a "miracle" is an overstatement. A 2021 systematic review in the Journal of Ethnopharmacology concluded that ashwagandha extract appears more effective than placebo for reducing stress and anxiety scores, with effects considered "moderate." However, the evidence has limitations, including variability in extract formulations, dosages, and study durations. Most trials are relatively short-term (8-12 weeks), and long-term efficacy and safety data are sparse. It functions as an adaptogen, meaning it may help the body modulate its stress response, but it is not a substitute for professional mental health care in cases of diagnosed anxiety disorders. The response is also individual; what works for some may not work for others.

Expert Insight: Clinicians view ashwagandha as a potential complementary tool within a broader stress-management strategy, not a first-line or standalone treatment. Its mechanism is not fully elucidated, and its effects are generally subtler than pharmaceutical anxiolytics. We advise against expecting dramatic, immediate transformations.

What are the most concerning side effects or risks that people often overlook?

Beyond commonly mentioned mild GI upset, several clinically significant risks are under-recognized. A paramount concern is its potential to induce or exacerbate thyroid hormone excess (hyperthyroidism), as it may stimulate thyroid hormone production. Individuals with thyroid disorders, especially Hashimoto's or Graves' disease, should use extreme caution. Ashwagandha may also lower blood pressure and blood sugar, posing risks for those on antihypertensive or antidiabetic medications. Furthermore, due to its potential immune-modulating effects, it is contraindicated for individuals with autoimmune conditions (e.g., rheumatoid arthritis, lupus) unless under direct specialist supervision. Liver toxicity (hepatotoxicity) has been reported in rare cases, highlighting the need for monitoring.

Who should absolutely avoid taking ashwagandha?

Certain populations should avoid ashwagandha unless explicitly advised by a physician familiar with their full history. This includes: Pregnant or breastfeeding women, due to a lack of safety data and theoretical risk of miscarriage; individuals with autoimmune diseases; those with hormone-sensitive cancers (e.g., prostate, breast) as it may influence hormone pathways; and people scheduled for surgery, due to its potential effects on blood pressure and central nervous system depression. Additionally, anyone with known liver disease or taking medications metabolized by the liver (via cytochrome P450 pathways) should avoid it, as herb-drug interactions are poorly mapped.

Expert Insight: A common oversight is self-prescribing ashwagandha while on other supplements or medications. It can interact with sedatives, thyroid hormone replacement, and immunosuppressants. The principle "natural does not equal safe" is critically important here. A full medication and supplement review is essential before starting.

When should I talk to my doctor, and what information should I bring to that appointment?

Consult a physician before starting ashwagandha if you have any pre-existing medical condition or take any prescription medications. Schedule a follow-up if you experience symptoms like palpitations, unexplained weight loss, severe fatigue, jaundice (yellowing skin/eyes), or abdominal pain while taking it. For the conversation, bring: 1) The specific product label showing extract type (e.g., KSM-66®, Sensoril®), dosage, and standardisation; 2) A complete list of all medications and supplements you take, including dosages; 3) Your key health history (thyroid, autoimmune, liver, or psychiatric conditions); and 4) Your clear goals for taking it (e.g., "managing work stress"). This allows for a risk-benefit assessment tailored to you.

7. In-site article recommendations

Related articles (placeholder links):

How Strength Training Changed My Metabolism — 30-day Transformation StoryShocking Truth About GLP-1 Drugs and Surgical Candidates — 2026 DataWarning — Hidden Risks of Over-training Exposed by Sports Medicine DataResearch Shows Optimal Protein Intake for Gastric Bypass Patients5 Keto Dinner Recipes That Support Steady Weight Loss — Expert Approved

8. External article recommendations

External resources (placeholder):